Heparin Sodium Injection · #9 of 35 active shortages by FDA posting duration
Brand: HEPARIN SODIUM
FDA lists Heparin Sodium Injection as Active Shortage (Fresenius Kabi USA, LLC).
Availability on file: Unavailable
Heparin Sodium Injection: Active Shortage
Unavailable 10 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Heparin Sodium Injection
- Manufacturer
- Fresenius Kabi USA, LLC
- Dosage Form
- Injection
- Presentation
- Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-10)
- Package NDC
- 63323-519-10
Status & Timeline
- Status
- Active Shortage
- Availability
- Unavailable
- First Reported
- Nov 14, 2017
- Last Updated
- Feb 25, 2026
- Therapeutic Category
- Hematology
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Next release March 2026. Check wholesalers for inventory.
Full Drug Profile
heparin
Side effects, interactions, warnings & more
Nearby, Other Heparin Shortage Records
Heparin Sodium Injection
Fresenius Kabi USA, LLC
Injection
Heparin Sodium Injection
Hospira, Inc., a Pfizer Company
Injection
Heparin Sodium Injection
Hospira, Inc., a Pfizer Company
Injection
Heparin Sodium Injection
Baxter Healthcare
Injection
Heparin Sodium Injection
Baxter Healthcare
Injection
Heparin Sodium Injection
Baxter Healthcare
Injection
FDA reason on file: Next release March 2026. General shortage guidance lives on the tracker hub.